We generated a mouse model that recapitulated major features of this disease and used this model and patient samples to probe how hyperactive PI3Kδ fosters aberrant humoral immunity. We found that mutant PI3Kδ led to co-stimulatory receptor FOXO1 and pro-apoptotic and anti-apoptotic members of the BCL-2 family. Notably, aberrant responses were accompanied by increased reactivity to gut bacteria and a broad increase in autoantibodies that were dependent on stimulation by commensal microbes. Our findings suggest that proper regulation of PI3Kδ is critical for ensuring optimal host-protective humoral immunity despite tonic stimulation from the commensal microbiome.
p 110δ , a catalytic subunit of phosphatidylinositol-3-OH kinase (PI3K) expressed mainly in hematopoietic cells, is activated by cytokine, antigen and co-stimulatory receptors and coordinates signaling involved in the activation and differentiation of T cells and B cells 1 . Patients with gain-of-function point mutations in the gene encoding p110δ (PIK3CD) exhibit the primary immunodeficiency PASLI ('p110δ -activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency'), also known as APDS ('activated-PI3Kδ syndrome'; called ' APDS' here), characterized by lymphopenia, lymphoproliferation, recurrent respiratory infections and mucosal lymphoid follicles. Such patients display an increased abundance of effector T cells and a reduced abundance of naive T cells, enlarged germinal centers (GCs), fewer class-switched memory B cells, and impaired antibody responses to vaccination [2] [3] [4] . However, the cellular and molecular events that contribute to these phenotypes remain to be characterized.
Clues to how altered activity of PI3K p110δ (PI3Kδ ) might disrupt antibody responses have been provided by work demonstrating that T cells and B cells intimately act together in antigen-driven antibody responses via the generation of GCs, which are specialized microenvironments for immunoglobulin class switching, affinity maturation and the development of memory B cells and long-lived plasma cells 5 . GCs also help maintain tolerance through the elimination of self-reactive clones 6 . CD4 + follicular helper T cells (T FH cells) provide essential signals for the formation and maintenance of GCs, as well as for the survival and selection of B cells that produce high-affinity antibodies 7, 8 and the deletion of potentially autoreactive B cells 9 . T FH cells express the chemokine receptor CXCR5, the inhibitory receptor PD-1, the co-stimulatory receptor ICOS and the transcription factor BCL-6 10 . In activated T cells, ICOS potently activates PI3Kδ , which leads to inactivation of FOXO1, a transcriptional repressor of Bcl6 11, 12 . In B cells, PI3Kδ is critical for their survival, proliferation and differentiation, acting via the integration of signals from the B cell antigen-receptor (BCR), the co-stimulatory receptors CD19 and CD40, the receptor for the B cell-stimulatory molecule BAFF, cytokines and Toll-like-receptors (TLRs) 13 . Notably, mice that lack PI3Kδ activity have defective formation of T FH cells and GCs 14, 15 , which demonstrates important roles for PI3Kδ in GC reactions. Furthermore, almost half of patients with APDS display autoantibodies and autoimmune-mediated organ damage 4, 16 , which Articles NaTure ImmuNOLOGy suggests that regulation of PI3Kδ activity is also important for limiting self-reactivity. These findings raise the possibility that GCs might be a major site of aberrant activity by lymphocytes expressing mutant PI3Kδ .
Here we generated a mouse model of APDS (Pik3cd E1020K/+ mice) and used this model to study how overactive PI3Kδ (PI3Kδ E1020K ) affects humoral responses, focusing on GCs. We found that PI3Kδ E1020K led to exaggerated production of T FH cells and GCs, associated with lymphocyte hypereactivity, altered regulation of FOXO1 and a member of the BCL-2 family, and increased B cell survival. Nonetheless, Pik3cd E1020K/+ mice displayed a diminished capacity for the production of robust class-switched antigen-specific antibodies in response to immunization, despite augmented anti-self and anticommensal responses. Notably, treatment of Pik3cd E1020K/+ mice with antibiotics revealed a requirement for commensal stimulation in the generation of hyperactivated immunophenotypes. Our results suggest that tight regulation of PI3Kδ activity is critical for constraining tonic activation induced by the commensal microbiome while facilitating protective immune responses. 17 . Despite their impaired antigen-specific responses to vaccination 2,3 , we found a greater frequency of CD4 + CD45RA -CD25 -CXCR5 + cT FH cells in patients with APDS than in healthy donors (Fig. 1a ). The cT FH cells from the patients also exhibited elevated expression of PD-1 (Fig. 1b) , which is associated with enhanced effector phenotypes and ongoing GC reactions 18 . Furthermore, the patients exhibited a greater frequency of CXCR3 + T FH cells than that of healthy donors ( Fig. 1c ), consistent with a bias toward T FH 1 cells, which do not effectively help naive B cells in vitro 17 . Thus, the patients with APDS showed altered homeostasis of effector CD4 + T cell populations that influence humoral responses.
Results

Patients with APDS display an increased abundance of blood T FH cells. Circulating T FH cells (cT FH cells) increase in abundance after immunization and in autoimmune conditions and reflect true T FH cells residing in secondary lymphoid organs
Pik3cd E1020K/+ mice recapitulate features of APDS. To explore the effect of hyperactivated PI3Kδ on immune responses, we generated a mouse model that expressed p110δ E1020K , which corresponds to the most common gain-of-function substitution in p110δ (E1021K) in patients with APDS 2,4 ( Supplementary Fig. 1a ). Heterozygous Pik3cd E1020K/+ mice recapitulated many features of APDS 2,4 , including fewer circulating white blood cells ( Fig. 2a ), lymphadenopathy ( Supplementary Fig. 1b ) and increased splenic cellularity (Fig. 2b) , relative to that of wild-type mice.
The most common clinical phenotype of patients with APDS is recurrent respiratory infections, often associated with lung and tracheal mucosal nodules 4, 16 . Additionally, ~30% of the patients display enteropathy with gastrointestinal nodular mucosal lymphoid hyperplasia 4, 16 . Similar to results obtained for patients, we found evidence of perivascular and peribronchiolar lymphoid aggregates in the lungs of the mutant mice ( Fig. 2c, left) and an increased number and size of isolated lymphoid follicles in the small intestines of the mutant mice, relative to those of wild-type mice (Fig. 2c, right) . These similarities suggested that Pik3cd E1020K/+ mice would provide a useful tool with which to delineate the cellular and molecular mechanisms that contribute to the corresponding human disease.
To evaluate how PI3Kδ specifically affects lymphocytes, we assessed T cell and B cell populations. Despite the similar frequency of CD4 + T cells in mutant and wild-type mice, we found a lower frequency of naive CD4 + T cells and a greater frequency of activated CD4 + T cells in the spleen and peripheral lymph nodes (LNs) of mutant mice than in those of wild-type mice ( Fig. 2d and Supplementary Table 1) , Fig. 1c ).
A partial block in the development of B cells is seen in patients with APDS, with increased circulating transitional CD20 + CD10 + B cells 4, 19 . Although the frequency of splenic B cells in mutant mice was similar to that of wild-type mice ( Supplementary Table 1 ), Each symbol (a,b,d-i) represents an individual mouse (wild-type, n = 8 (a,b,e-h), n = 5 (d) or n = 13 (i); Pik3cd E1020K/+ , n = 6 (a,b,e-h), n = 5 (d) or n = 7 (i)). Data are representative of three independent experiments (mean + s.e.m. in a,b,d-i). *P < 0.05, **P < 0.01 and ***P < 0.001 (Mann-Whitney U-test).
Articles
NaTure ImmuNOLOGy mutant mice had a greater number of and altered populations of CD93 + transitional B cells, including more T1 cells, consistent with a partial developmental block ( Supplementary Fig. 1d ). Additionally, mutant mice had altered surface expression of immunoglobulin M (IgM) and IgD, fewer follicular B cells and more marginal-zone B cells, relative to that of wild-type mice ( Supplementary Fig. 1e ,f), in support of the proposal of a role for PI3Kδ in driving the differentiation of marginal-zone B cells 20 . Finally, mutant mice had more peritoneal B-1a cells ( Supplementary Fig. 1g,h) , a self-reactive and/or innate-like population 21 . Therefore, Pik3cd E1020K/+ mice developed T cells and B cells but exhibited alterations in the activation and homeostasis of lymphocytes, as seen in the corresponding human patients.
Elevated activation of lymphocytes in Pik3cd E1020K/+ mice.
Consistent with observations of patients' blood, we found a greater frequency of PD-1 + CXCR5 + CD4 + T cells in the spleen of Pik3cd E1020K/+ mice than in that of wild-type mice ( Fig. 2e ). These included both Foxp3 -T FH cells and Foxp3 + follicular helper regulatory T cells (T FR cells) ( Fig. 2f ), yet the ratio of T FH cells to T FR cells in the mutant mice remained similar to that of wild-type mice ( Supplementary Table 1 ). Both BCL-6 lo pre-T FH cell and BCL-6 hi GC T FH cell populations were expanded ( Supplementary Fig. 2a ). Furthermore, although 2-month-old mutant mice exhibited a relatively normal number of T FH cells in the peripheral LNs, the frequency and number of these cells increased in both the LNs and the spleen as mice aged (Supplementary Fig. 2b and Supplementary  Table 1 ). In mutant mice, by 1 year of age, the majority of CD4 + T cells had abundant expression of PD-1, ICOS and CXCR5 ( Supplementary Fig. 2c ).
In parallel, we detected substantially more GC B cells in both the LNs and the spleen, as well as more splenic CD138 + plasma cells and plasmablasts, in mutant mice than in wild-type mice (Fig. 2g,h and Supplementary Fig. 2d ). Consistent with timedependent increases in lymphocyte activation, these phenotypes became more pronounced in mutant mice with age, together with a reduction in the abundance of IgD + naive B cells ( Supplementary  Fig. 2d ,e and Supplementary Table 1 ). Accordingly, we observed a higher concentration of IgM and IgG in the serum of mutant mice than in that of wild-type mice ( Fig. 2i ). An elevated concentration of serum IgM is also seen in patients with APDS, although IgG concentrations are variable [2] [3] [4] . Thus, like the corresponding patients, Pik3cd E1020K/+ mice displayed expanded activated lymphocyte populations associated with increased antibody production.
Defective T cell-dependent humoral responses.
To explore the effect of activated PI3Kδ on antigen-induced humoral responses, we immunized mice subcutaneously with the T cell-dependent antigen NP-OVA (4-hydroxy-3-nitrophenylacetyl conjugated to ovalbumin) in alum. Mice were immunized at 2 months of age, when the frequency of T FH cells in mutant mice was relatively normal, or at 4 months of age, when mutant mice exhibited a greater abundance of T FH cells and GC B cells, similar to the corresponding patients. As expected, after immunization, the frequency of T FH cells and GC B cells increased in the draining LNs (dLNs) relative to their frequency in the resting LNs (rLNs) in both age groups of wild-type mice ( Fig. 3a and Supplementary Fig. 3a) . Similarly, the frequency of T FH cells and GC B cells increased after immunization in young (2-month-old) mutant mice ( Supplementary Fig. 3a ). In contrast, immunization did not increase the frequency of T FH cells or GC B cells in the dLNs of 4-month-old mutant mice ( Fig. 3a ). Furthermore, while at baseline, mutant rLNs had greater cellularity than that of wild-type rLNs, after immunization, mutant dLNs had a number of cells comparable to or even lower than that of wild-type dLNs ( Supplementary Fig. 3b ).
Despite the greater frequency of GC B cells in mutant mice, the frequency and number of antigen-binding (NP + ) GC B cells were lower, so that the ratio of NP + antigen-specific GC B cells to NP -GC B cells was much lower in mutant mice than in wild-type mice (Fig. 3b ,c and Supplementary Fig. 3c ). The mean fluorescent intensity of NP-binding cells was also lower in mutant mice than in wildtype mice (Fig. 3b ), which might have reflected a lower abundance of BCRs on the surface of mutant cells. These phenotypes became even pronounced by 1 year of age, when many mutant mice had very few NP-specific GC B cells after immunization ( Supplementary  Fig. 3d ). However, a lower ratio of NP + GC B cells to NP -GC B cells was also observed in 2-month-old mutant mice, relative to that in age-matched wild-type mice ( Supplementary Fig. 3e ), which suggested that these observations were not solely the result of the prevention of new antigen-specific responses via an increased abundance of pre-existing GCs. Within the NP + GC B cell compartment, we found a lower frequency of IgG1 + cells in mutant mice than in wild-type mice ( Fig. 3d ), indicative of impaired class switching in the mutant mice.
Analysis of antibody concentrations in serum revealed a wide range of abundance for NP-specific IgM in Pik3cd E1020K/+ mice that overlapped that of wild-type ( Fig. 3e ). However, consistent with impaired class switching, NP-specific IgG1 was significantly lower in abundance in mutant mice than in wild-type mice ( Fig. 3f ), despite the finding of greater total IgG1 in the serum of mutant mice, probably a result of an increased abundance of activated B and plasma cells ( Supplementary Fig. 3f ). Nonetheless, the ratio of high-affinity antibodies to NP 4 to total antibodies to NP 20 in serum, which is often used to evaluate affinity maturation 22 , in wild-type mice was similar to that in mutant mice ( Fig. 3f ). Thus, Pik3cd E1020K/+ mice exhibited marked alterations in humoral immunity, characterized by increased basal formation of GCs, but defects in the magnitude of class-switched antigen-specific antibody responses.
Hyperactivated-PI3Kδ results in disorganized GCs. To provide further insight into the nature of the defects reported above, we used high-dimensional immunofluorescence confocal microscopy to evaluate the structure and organization of GCs ( Fig. 3g ). To model the immune-system activation observed in the corresponding patients, we evaluated 4-month-old mice both at steady state and after immunization. In line with our flow analyses, wild-type rLNs had very few, poorly formed GCs within the follicular dendritic cell (FDC) networks ( Fig. 3g , far left); however, after immunization, we observed increased generation of GCs, as indicated by BCL-6 + cells in the dLNs ( Fig. 3g , middle left). In contrast, the rLNs of mutant mice already had expanded GC areas that filled the FDC networks ( Fig. 3g , middle right). Almost all FDC areas were occupied with BCL-6 + GCs in the dLNs of both wild-type mice and mutant mice, but, strikingly, they were also similarly occupied in the rLNs of mutant mice ( Supplementary Fig. 3g ).
Enlargement of a wild-type GC permitted identification of the dark zone (DZ), which showed enrichment for tightly packed BCL-6 + GC B cells, and the light zone (LZ), which was demarcated by CD35 + FDCs and included the bulk of the PD-1 + CD4 + T FH cells ( Fig. 3g , middle left column, middle and bottom rows). Although the size of mutant dLN GCs varied ( Supplementary Fig. 3h ), GCs from both mutant rLNs and mutant dLNs showed altered organization, with more invasion of the DZ by T FH cells (Fig. 3g , middle and far right columns, middle and bottom rows). Those findings were confirmed by histo-cytometry quantifying T FH cells per DZ area ( Supplementary Fig. 3i -k). Flow cytometry further showed a reduction in the DZ and a greater frequency of LZ NP + GC B cells in mutant mice than in wild-type mice, as identified by expression of the chemokine receptor CXCR4 and the co-stimulatory molecule CD86 (B7-2) 23 ( Supplementary Fig. 3l ). A greater frequency of Foxp3 + regulatory T cells and T FR cells in mutant mice than in Articles NaTure ImmuNOLOGy wild-type mice was also observed (Fig. 3g , middle and far right), as confirmed by flow cytometry ( Supplementary Fig. 3m ); however, T FR cells were seen at the T cell-B cell border and within the B cell follicles in both wild-type mice and mutant mice, consistent with a published study 24 . Thus, Pik3cd E1020K/+ mice exhibited disorganized GCs with extensive infiltration of T FH cells into the DZ and poor demarcation of LZ and DZ areas, indicative of a dysregulated immune response.
Increased T FH cell differentiation is T cell intrinsic.
The formation of GCs involves intimate interactions and crosstalk between antigen-specific T FH cells and B cells. To probe the distinct cellular contributions to the altered humoral phenotypes, we transferred naive Pik3cd +/+ or Pik3cd E1020K/+ OT-II cells (which have transgenic expression of an OVA-specific T cell antigen receptor) into wild-type hosts, which we then immunized intraperitoneally with NP-OVA ( Fig. 4a ). At 8 d after immunization, Pik3cd +/+ or Pik3cd E1020K/+ OT-II cell populations had expanded similarly ( Fig. 4b ) and were homogeneously CD44 hi ( Supplementary Fig. 4a ). However, a greater frequency of the Pik3cd E1020K/+ OT-II cells than Pik3cd +/+ OT-II cells had acquired the expression of T FH cell markers ( Fig. 4c ), including markers of both pre-T FH cells and GC T FH cells ( Supplementary Fig. 4b ). Notably, Pik3cd E1020K/+ T FH cells produced the cytokine IL-21 and provided in vitro help to B cells similarly to their wild-type counterparts ( Supplementary Fig. 4c,d ), consistent with normal function. Thus, the Pik3cd E1020K/+ mutation drove a cellintrinsic population expansion of T FH cells.
ICOS-independent generation of T FH cells. ICOS is a critical
receptor that activates PI3Kδ and is essential for T FH cell differentiation 15 . Since p110δ E1020K was constitutively active, we hypothesized that it might bypass requirements for interactions between ICOS and its ligand (ICOS-L) in the development of T FH cells. To test this, we transferred naive Pik3cd +/+ or Pik3cd E1020K/+ OT-II cells into wild-type mice, which we then immunized with NP-OVA in alum and treated with a blocking antibody to ICOS-L (anti-ICOS-L) ( Fig. 4d ). Treatment with anti-ICOS-L decreased the frequency of Pik3cd +/+ OT-II T FH cells but failed to effectively block the differentiation of Pik3cd E1020K/+ OT-II T FH cells ( Fig. 4e ), despite its reducing the frequency of endogenous wild-type T FH cells in the same mice ( Supplementary Fig. 4e ). Furthermore, although treatment with anti-ICOS-L reduced the frequency of both T FH cells and GC B cells in intact wild-type mice, neither population was abolished in the mutant mice ( Supplementary Fig. 4f -h). Thus, activated PI3Kδ overcame requirements for ICOS-ICOS-L interactions in the differentiation and maintenance of T FH cells.
In vitro stimulation of naive OT-II cells with OVA peptide (amino acids 232-339) revealed augmented induction of activation markers on mutant cells ( Supplementary Fig. 4i ), suggestive of increased sensitivity to stimulation. Similarly, when we assessed phosphorylation of the kinase AKT and ribosomal protein S6 induced via the T cell antigen receptor plus the co-receptor CD28 (downstream 'readouts' of PI3K activity), we observed enhanced phosphorylation of AKT and S6 in Pik3cd E1020K/+ CD4 + T cells relative to that in wildtype CD4 + T cells ( Fig. 4f ), as seen in patients' cells [2] [3] [4] . Activated phosphorylated AKT (p-AKT) phosphorylates transcription factors of the FOXO family, which leads to their sequestration outside of the nucleus and subsequent degradation 25 . Intriguingly, in the absence of FOXO1, T FH cells are also generated independently of ICOS 11 . To evaluate FOXO1 in this context, we activated T cells in vitro to induce expression of ICOS, allowed them to 'rest' and then re-stimulated them with anti-ICOS. After being activated in vitro, wild-type CD4 + T cells included a distinct population of cells that stained for p-FOXO1, and this population increased further after re-stimulation with anti-ICOS ( Fig. 4g ). In contrast, Pik3cd E1020K/+ T cells exhibited abundant p-FOXO1 even before re-stimulation with anti-ICOS ( Fig. 4g ). Furthermore, expression of FOXO1 AAA , an AKT-resistant FOXO1 mutant 26 , decreased the frequency of mutant T FH cells generated in vivo to a frequency similar to that of Pik3cd +/+ FOXO1 AAA OT-II T FH cells ( Fig. 4h ), in addition to reducing the overall accumulation of T cells, as previously reported 11 (data not shown). Thus, the expression of activated PI3Kδ bypassed the need for ICOS to phosphorylate and inactivate FOXO1, an inhibitor of T FH cell differentiation.
Increased abundance of GC B and plasma cells but diminished antigen-specific responses. Despite their greater T FH cell differentiation than that of Pik3cd +/+ OT-II cells after immunization with NP-OVA, the transfer of Pik3cd E1020K/+ OT-II cells into wild-type hosts was not sufficient to generate a greater number of GC B cells, at least within the time frame of analysis ( Supplementary Fig. 4j ). To investigate B cell-intrinsic roles of activated PI3Kδ , we transferred naive Pik3cd +/+ or Pik3cd E1020K/+ MD4 B cells (which have transgenic expression of a hen-egg lysozyme (HEL)-specific BCR), together with naive Pik3cd +/+ OT-II cells, into wild-type mice, which we then immunized with a fusion of HEL and an OVA peptide of amino acids 323-339 (ref. 22 Supplementary Fig. 5a ). However, Pik3cd E1020K/+ MD4 B cells expanded more ( Fig. 5b ) and displayed greater differentiation into GC B cells ( Fig. 5c ) than did Pik3cd +/+ MD4 B cells, indicative of cell-intrinsic phenotypes.
To evaluate antigen-specific responses, we transferred wild-type or Pik3cd E1020K/+ naive polyclonal B cells, together with Pik3cd +/+ naive OT-II cells, into wild-type MD4 host mice, which we then immunized with NP-OVA ( Supplementary Fig. 5b ). In this setting, only the transferred polyclonal B cells can respond to the immunogen. Again, we observed greater population expansion of mutant B cells than of wild-type B cells ( Supplementary Fig. 5c ), as well as increased numbers of GC B cells and splenic plasma cells ( Supplementary Fig. 5d ,e) after immunization. Nonetheless, the frequency of NP + GC B cells, as well as the ratio of NP + GC B cells to NP -GC B cells, was lower for the transferred mutant B cells than for their wild-type counterparts ( Supplementary Fig. 5f ).
In vitro stimulation of Pik3cd E1020K/+ MD4 follicular B cells with HEL revealed greater induction of activation markers in those cells than in Pik3cd +/+ MD4 B cells ( Supplementary Fig. 5g ), suggestive of a lower threshold of activation, despite comparable expression of activation markers before stimulation. We also observed greater proliferation of and incorporation of the thymidine analog BrdU into mutant follicular B cells in response to various stimuli in vitro ( Fig. 5d,e ), consistent with B cell-intrinsic effects of PI3Kδ E1020K . Additionally, in vitro activation of mutant B cells led to greater plasma-cell differentiation ( Fig. 5f , left, and Supplementary  Fig. 5h ) and less switching to IgG1 (Fig. 5f, right) , both of which occurred mainly in cells that had undergone extensive proliferation, as in wild-type cultures. These phenotypes paralleled findings obtained in vivo and were reversed by a selective inhibitor of PI3Kδ (Fig. 5g ). Together these data indicated that PI3Kδ E1020K caused B cell-intrinsic increases in the outgrowth of GC B cells and plasma cells but impaired the capacity of B cells for class-switched antigen-specific responses.
PI3Kδ E1020K results in reduced death of GC B cells. In GCs, B cells undergo high rates of death, which results in the culling of lowaffinity and non-antigen-specific B cells that is needed to generate proper antigen-specific antibody responses 6 . In contrast, ex vivo Pik3cd E1020K/+ GC B cell populations included a greater frequency of live GC B cells and less staining for activated caspase-3 than that of their wild-type counterparts (Fig. 5h,i) . That enhanced survival seemed to be B cell intrinsic, as mixed-bone marrow chimeras generated with wild-type and mutant cells had a greater frequency of Isotype or anti-ICOS-L i.p. Articles NaTure ImmuNOLOGy GC B cells, as well as live cells within the mutant GC B cell compartment ( Supplementary Fig. 5i,j) . Although differences in the in vitro steady-state survival of unstimulated naive follicular B cells were not observed ( Supplementary Fig. 5k ), various stimuli, including anti-IgM and lipopolysaccharide (LPS), increased the frequency of live mutant proliferating cells ( Supplementary Fig. 5l ). Moreover, IL-4 increased the survival of mutant B cells relative to that of wildtype B cells, even in the absence of proliferation ( Supplementary  Fig. 5m ). In contrast, BAFF did not increase survival of mutant B cells but consistently led to the proliferation of mutant B cells, a result not observed for wild-type cells ( Supplementary Fig. 5m ). Treatment with the selective inhibitor of PI3Kδ reduced both the proliferation and the viability of B cells in vitro ( Supplementary  Fig. 5n ), which directly linked activated PI3Kδ to those phenotypes. Thus, PI3Kδ E1020K increased both the survival and the proliferation of activated B cells.
FOXO proteins transcriptionally activate genes encoding proapoptotic molecules, such as Bcl2l11, which encodes the BCL-2 family member BIM 27 . As in T cells, we observed increased phosphorylation of AKT and S6 (Fig. 5j) , as well as a greater frequency of p-FOXO1 + Pik3cd E1020K/+ B cells than of wild-type cells (Fig. 5k ), after in vitro stimulation. Consistent with those observations, mutant GC B cells exhibited lower expression of Bcl2l11 than that of wild-type cells (Fig. 5l ). AKT-mediated phosphorylation also inhibits the kinase GSK3β , which targets the anti-apoptotic BCL-2 family member MCL-1 for proteasome degradation 28 . Accordingly, in vitro stimulation resulted in higher expression of MCL-1 in mutant B cells than in wild-type B cells (Fig. 5m ). Thus, activated PI3Kδ regulated multiple pathways that promote B cell survival.
Pik3cd E1020K/+ mice display elevated serum autoantibodies. The induction of B cell apoptosis within the GC is essential for the maintenance of self-tolerance through the elimination of selfreactive clones 6 . Notably, many patients with APDS are positive for autoantibodies and develop autoimmune manifestations, such as glomerulonephritis 16 . Similarly, we found a higher concentration of IgG and IgM anti-nuclear antibodies in the serum of mutant mice than in that of wild-type mice ( Fig. 6a and Supplementary Fig. 6a ). Evaluation with an array of 94 different autoantigens revealed that IgM and IgG antibodies directed against approximately 50 autoantigens had significantly greater reactivity in mutant mice than in wild-type mice ( Fig. 6b, Supplementary Fig. 6b and Supplementary  Table 2 ). Moreover, 1-year-old mutant mice exhibited lymphocytic infiltration in multiple organs (Fig. 6c ). Thus, Pik3cd E1020K/+ mice exhibited increased self-reactive antibodies and lymphocytic infiltration of tissues that worsened with age.
Increased gut-associated GCs with a greater abundance of IgA-coated fecal bacteria. It is now appreciated that there are numerous connections between the commensal microbiome and autoimmunity 29 . To evaluate whether the microbiota contributed to the activated phenotypes of Pik3cd E1020K/+ mice, we assessed mesenteric lymph nodes (mLNs) and Peyer's patches (PPs), which are continuously exposed to a wide range of microbiota and foodderived antigens that sustain the generation of T FH cells and GC B cells 30 . Again, we found increased cellularity, as well as a greater number of T FH cells and GC B cells, in mutant mLNs and PPs than in their wild-type counterparts (Fig. 7a,b ). Furthermore, whereas wild-type mLNs had GCs predominantly in the cortical region, mutant mLNs displayed a greater abundance of GCs scattered throughout the internal medullary area ( Supplementary  Fig. 7a,b ). Mutant mLNs also displayed disorganization of GCs, with poor demarcation of DZ and LZ areas, and infiltration of PD-1 + T FH cells into the DZ ( Supplementary Fig. 7a,c,d) , as in peripheral LNs.
T FH cells have a crucial role in supporting the selection of GC B cells and their differentiation into IgA-secreting plasma cells in response to commensal stimulation in gut 31 . Accordingly, a greater abundance of free fecal IgA, as well as a greater frequency of fecal IgA-coated bacteria, were detected in Pik3cd E1020K/+ mice than in Articles NaTure ImmuNOLOGy wild-type mice (Fig. 7c,d) . To identify the taxa of gut bacteria 'preferentially' targeted by IgA, we sorted IgA-coated and uncoated bacteria and sequenced 16 S rRNA in wild-type and Pik3cd E1020K/+ mice. Many taxa of bacteria exhibited greater IgA coating in Pik3cd E1020K/+ mice than in wild-type mice. Although these results did not reach statistical significance after correction for multiple testing, these taxa outnumbered those less targeted by IgA in Pik3cd E1020K/+ mice than in wild-type mice ( Fig. 7e and Supplementary Table 3 ).
Intriguingly, these included Akkermansia muciniphila, a commensal bacterium that is very abundant in the human gut 32 (Fig. 7f ). The overall community structure of the microbiota of wild-type mice did not differ consistently from that of mutant mice ( Supplementary  Fig. 7e,f) . However, phylogenetic diversity, which reflects the richness in number and phylogenetic distribution of taxa within a single community, was significantly lower in mutant mice and was inversely correlated with the frequency of IgA-coated bacteria Articles NaTure ImmuNOLOGy (Fig. 7g,h) , similar to findings noted for mouse models with strong mucosal IgA responses 33 .
Heightened systemic responses to gut bacteria. Given potential connections between autoreactive antibodies and anti-commensal antibodies 29 , we assessed anti-commensal IgG in the serum. We detected a significantly higher frequency of IgG2a/b that bound fecal bacteria in the serum of mutant mice than in that of wild-type mice (Fig. 8a) , indicative of greater systemic responses to gut commensals. Moreover, we found more binding of IgG to A. muciniphila, but not to the control bacterium Lactobacillus reuteri, in mutant mice than in wild-type mice (Fig. 8b) , in support of the proposed specificity of these responses.
Furthermore, mutant splenic follicular B cells showed greater responsiveness to autologous fecal microbiome extracts and a lower threshold for the expression of activation markers in response to autologous fecal microbiome extracts (Fig. 8c) , as well as to LPS, an innate TLR agonist released by gut bacteria (Fig. 8d ), relative to that of wild-type splenic follicular B cells. Thus, the Pik3cd E1020K/+ mutation increased both antigen-specific reactivity and innate reactivity to commensal-derived products.
Antibiotics diminish activated phenotypes and autoantibodies.
To evaluate potential connections between anti-commensal responses and autoimmunity, we assessed the antibodies that specifically bound fecal bacteria. Mutant serum antibodies that bound Articles NaTure ImmuNOLOGy gut bacteria and were subsequently eluted showed greater binding of double-stranded DNA than that of their wild-type counterparts (Fig. 8e ), suggestive of possible cross-reactivity with self antigens.
To determine whether gut commensals directly contributed to the immune-system activation in Pik3cd E1020K/+ mice, we treated wild-type and mutant littermates with a 'cocktail' of antibiotics for 6 weeks, beginning at the time of weaning. Treatment with antibiotics reduced splenic cellularity, as well as the number of activated CD4 + T cells and T FH cells and the frequency and number plasma cells and plasmablasts, in the spleen of mutant mice, but not in that of wild-type mice (Fig. 8f-i) . Notably, treatment of mutant mice with antibiotics reduced the abundance of total IgG, as well as antibodies directed against double-stranded DNA and various self antigens, to levels seen in untreated wild-type mice (Fig. 8j-l) . Thus, the generation of hyperactivated and autoreactive phenotypes in Pik3cd E1020K/+ mice required signals derived from commensal stimuli.
Discussion
In a mouse model that recapitulated features of APDS, we found a greater abundance of T FH cells and GC B cells but inefficient class-switched antigen-specific B cell responses to immunization. Nonetheless, the Pik3cd E1020K/+ mice exhibited a greater abundance Articles NaTure ImmuNOLOGy of antibodies to commensal bacteria and self antigens, the latter of which were strikingly diminished by treatment with antibiotics. Our data suggested that PI3Kδ selectively controlled lymphocyte activation, allowing the efficient generation of protective responses while preventing excessive reactivity to tonic stimulation by commensals that can promote lymphoid dysregulation. Several factors might have contributed to the aberrant humoral immunity of Pik3cd E1020K/+ mice. T FH cells, which are normally confined to the LZ, specifically target high-affinity B cells, inducing survival and proliferation. In contrast, an increased number of T FH cells might diminish competition for the survival signals provided to B cells and paradoxically impair specific responses 22 . Furthermore, T FH cells abnormally located in the DZ in mutant GCs might drive inappropriate signals 34 , including PI3K-mediated pathways in B cells. Of note, patients with APDS also show disrupted GC architecture with increased invasion by T FH cells 16 . This mis-localization of T FH cells is intriguing, given that PI3K pathways regulate multiple molecules involved in lymphocyte migration 1 . Our analyses also revealed an increased abundance of Foxp3 + regulatory T cells and T FR cells in mutant mice. However, while an increased ratio of T FR cells to T FH cells can impair humoral responses 35 , we observed a ratio in mutant mice similar to that of wild-type mice. Finally, an increased abundance of GC B cells and T FH cells, which completely fill the FDC networks over time, probably contribute to the impaired development of new antigen-specific responses, particularly with age.
Like FOXO1-deficient T cells 11 , mutant CD4 + T cells exhibited ICOS-independent differentiation into T FH cells. However, despite published data indicating a more important role for PI3Kδ in T FH cells than in GC B cells 15 , we found that Pik3cd E1020K/+ B cells intrinsically generated more GC B cells and plasma cells, with increased p-FOXO1. Mirroring the requirements for FOXO1 in DZ formation, regulation of the cytidine deaminase AID and the generation of antigen-specific responses 36, 37 , Pik3cd E1020K/+ mice also had defective switching to IgG1 and a lower ratio of DZ to LZ. Thus, the phenotypes of cells in Pik3cd E1020K/+ mice recapitulated the phenotypes of FOXO1-deficient T cells and B cells, although they were less severe.
Published data obtained with an activated, ubiquitously expressed p110α isoform support the proposal that p110α has a role in tonic BCR signaling required for B cell survival 27 . Similarly, we found increased survival of PI3Kδ E1020K/+ activated B cells, associated with altered expression of BIM and MCL-1. Interestingly, BIM-deficient mice succumb to systemic lupus erythematosus-like autoimmunity with accumulation of self-reactive lymphocytes and autoantibodies 38 . MCL-1 is critical for the formation of memory B cells and plasma cells 39, 40 . Together these factors might impair the selective pruning required for proper antigen-specific responses.
Pik3cd E1020K/+ mice exhibited greater lymphoid activation associated with gut-associated lymphoid tissue and a greater frequency of both fecal IgA-binding fecal bacteria and serum IgG-binding fecal bacteria. There is enrichment for IgA-coated bacteria among commensal pathobionts that can drive intestinal and systemic inflammation in particular disease settings 41 . Notably, we detected GCs in the medullary region of mutant mLNs, a finding that is normally observed only with inflammation 42 . Among the bacterial species 'preferentially' bound by IgA in mutant mice, we found A. muciniphila, which promotes IgA responses 32, 41 and is associated with protective effects in diabetic models 43 and cancer immunotherapy 44 . We speculate that alterations in the prevalence of substantially IgA-coated bacteria might amplify autoreactive responses under certain genetic conditions, such as in Pik3cd E1020K/+ mice.
Our data support the proposal of a strong connection between the microbiota and autoimmunity in APDS. Systemic responses to gut bacteria could neutralize commensals that spread systemically when gut barriers are leaky 45, 46 , as has been proposed for people deficient in the adaptor MYD88 or the kinase IRAK-4, who have a greater abundance of B cells that express the heavy-chain variable region V H 4-34, which cross-reacts with self antigens and commensals 47 . However, immune responses to microbiota might also amplify autoreactive lymphocytes, causing immunopathology in peripheral sites, as reported for other autoimmune conditions 29 . While altered gut integrity might contribute to increased anti-commensal reactivity, mucosal barriers seemed to be grossly intact in the mutant mice. We therefore speculate that activated PI3Kδ lowers the threshold for signaling from receptors on T cells and B cells, making them more susceptible to activation by commensal products physiologically released in the periphery. Although we found IgG reactive to A. muciniphila, but not IgG reactive to the control bacteria Lactobaccillus or to phosphorylcholine, which is used to identify polyreactive antibodies (data not shown), we cannot rule out the possibility of a general relaxation of tolerance and nonantigen-specific activation by gut bacteria. However, the elevated abundance of commensal antigen-specific IgG, in conjunction with the increased responsiveness of mutant B cells to autologous fecal material and LPS, would suggest that activated PI3Kδ drives hyper-responsiveness to both antigens and innate stimuli. In contrast, these commensal stimuli might be suboptimal for the triggering of downstream pathways in wild-type cells with appropriately controlled PI3Kδ activity. 
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Our findings emphasize the importance of PI3Kδ in the activation of T cells and B cells required for proper GC reactions, in which both too little PI3Kδ activity 15 and too much PI3Kδ activity disrupt humoral immunity. Notably, we have identified a previously unappreciated role for PI3Kδ in modulating responses to the commensal microbiota that, when not properly controlled, led to lymphoid hyper-reactivity that worsened with age. Published work has shown promising results for the treatment of patients with APDS with an inhibitor of PI3Kδ 48 ; however, the long-term consequences of this treatment remain unknown, especially given data demonstrating genomic instability associated with blockade of PI3Kδ 49 . Our work might provide new perspectives on managing patients with activated PI3Kδ , as well as other autoimmune conditions, including those induced by checkpoint-blockade therapy, in which dampening PI3K pathways might allow the selective control of immune responses. 
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Methods Patient samples. All human subjects and their guardians in this study signed written informed consent in accordance with Helsinki principles for enrollment in research protocols that were approved by the Institutional Review Board of NIAID (clinical trial registration number NCT00001355, US NIH). Blood from healthy donors was obtained at the NIH Clinical Center under approved protocols. All procedures were based on standard of care, under established clinical guidelines. Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll-Hypaque gradient centrifugation. Blood T FH cells were stained at 20 °C (room temperature) using antibodies indicated in the Nature Research Reporting Summary and figure legends.
Mice. C57BL/6 mice (000664), OT-II mice (004194), ZP3-Cre mice (003651), CD45.1 + mice (002014), BLIMP-1-YFP mice (008828) and MD4 mice (002595) were obtained from The Jackson Laboratory. Rosa26-HA-hFoxo1AAA (Foxo1 AAA ) mice 26 , were bred to OT-II Pik3cd E1020K/+ mice. To generate Pik3cd E1020K/+ mice, a targeting construct was built by mutation of Pik3cd exon 24 to introduce a G-to-A point mutation encoding E1020K and subcloning of flanking fragments into the PL452 vector. The targeting construct was linearized with NotI and was electroporated into HG-3 129/Sv × C57BL6/J ES cell line together with a TALEN that cut in the intron upstream of exon 24 to increase targeting. Genomic DNA was isolated from 48 G418-resistant embryonic stem-cell clones and was initially screened by PCR using outside primers for both targeting arms; four clones were confirmed positive by Southern blot analysis using DraI and ApalI and 5′ and 3′ flanking probes, respectively, and by sequencing for the point mutation. Cells were microinjected into blastocytes from C57BL6/J mice, and progeny positive for the targeted allele were crossed to ZP3-Cre mice to delete the neo r gene in the female germline. Positive mice were backcrossed to C57BL6/J mice, SNP genotyped (Dartmouse), to obtain mice that were > 99.6% C57BL6/J, and were maintained heterozygous for the mutated allele. For adoptive-transfer experiments, Pik3cd E1020K/+ mice were bred to OT-II or MD4 mice positive for the congenic marker(s) CD45.1 or CD45.2 or both. Mice were maintained and treated under specific pathogen-free (SPF) conditions in accordance with the guidelines of the NHGRI Animal Care and Use Committee at the NIH (protocol G98-3).
Mouse flow cytometry. Antibodies and dilutions are described in the Nature Research Reporting Summary. For staining, single-cell preparations were made from spleen and lymph node in MACS buffer (PBS with 2% FBS and 2 μ M EDTA). Staining panels containing anti-CD93 ( Supplementary Fig. 1d ) were performed in MACS buffer not supplemented with EDTA. After ACK (ammonium chloride) lysis of RBCs, cells were washed once, and Fc receptors blocked with anti-mouse CD16/32 (2.4G2, BioXCell). Cells were incubated with antibodies for 45-60 min on ice. Intracellular staining of BCL-6, Foxp3 and MCL-1 were performed using the Foxp3-staining buffer set from eBioscience. The following reagents were used according to the manufacturer's instructions: a PhiPhiLux-G1D2 kit (OncoImmunin), annexin V-FITC (BD Biosciences) and annexin V binding buffer (BioLegend), a CellTrace Violet (CTV) Cell Proliferation Kit (Life Technologies), A LIVE/DEAD Fixable Aqua Dead Cell Stain Kit and LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (Life Technologies). The following gates were applied before the identification of the specific cell types: FSC-A-SSC-A, exclusion of doublets (SSC-H-SSC-W and FSC-H-FSC-W), live cells (negative for Aqua or Near-IR dead stain kit); gating strategies for each population are indicated in each figure legend. Flow cytometry was performed on a LSRII (BD Biosciences) and data WERE analyzed using FlowJo 9.9 software (TreeStar).
ELISA. ELISA of total and antigen-specific immunoglobulin was performed as previously described 22 . Plates (Costar) were coated overnight with 5 μ g/ml antiimmunoglobulin (number) or NP 20 -BSA and NP 4 -BSA (Biosearch Technologies) in PBS at 4 °C. Plates were blocked with 1% BSA in PBS and serial dilutions of serum were applied, followed by incubated at 20 °C (room temperature) for 2-3 h. Subsequently, plates were washed (with 0.05% Tween20 in PBS) and incubated with alkaline phosphatase (AP)-conjugated anti-mouse immunoglobulin isotypespecific antibodies, followed by pNPP substrate (Sigma-Aldrich) as a detection reagent. Absorbance was measured at 405 nm with a microplate reader (Molecular Devices), and values were calculated according to immunoglobulin standards or to reference serum from wild-type mice immunized twice with NP 19 -OVA (results presented in arbitrary units). The ratio of NP 4 -binding antibodies to NP 20 -binding antibodies was calculated as an estimate for affinity maturation. ELISA of fecal IgA was performed as previously described 50 : fresh stools were collected, dissolved in PBS (100 μ l/0.01 g) and centrifuged, and IgA concentrations were determined by ELISA on the recovered supernatants. Antibodies and immunoglobulin standards were purchased from Southern Biotech.
Histology. Mouse organs were fixed overnight at 20 °C (room temperature) in neutral buffered formalin. After fixation, samples were dehydrated in 70% ethanol and embedded in paraffin, cut on a microtome (8-10 μ m) and stained with hematoxylin and eosin (Histoserv). Immunohistochemical images were acquired on an upright Zeiss Axio Imager D2 microscope (Carl Zeiss) with a 1 × , 5 × or 10 × objective lens, using a AxioCam HRc full color CCD camera. Zeiss ZEN blue pro 2011 software package was used for collection and for post-processing of the images. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
No statistical method was used to predetermine sample size. Sample size was determined based on previous and/pilot studies. In most experiments between 4-6 mice were used per group and guided by the 3R principles to reduce animal numbers.
Data exclusions No data were excluded from the analysis.
Replication
Biological and technical replicates have been performed. Most of the experiments have been reproduced 2-3 independent times with comparable results. Information on replicates is included in figure legends. Where representative data were shown, the experimental findings were reproduced with similar results.
Randomization For human samples: PI3Kd patients have been screened genetically prior to this work. Healthy donors (>18y age) were received from NIH blood bank, no information on these individuals is available. For mouse experiments: littermates from multiple breeding were randomly allocated to experiments but based on genotype, age and sex to control for covariates.
Blinding
For most of the experiments, investigators were not blinded. However, in most mouse experiments, isolation of organs and cells from mice were performed in a blinded fashion by a third party. The genotypes of patients and mice were known during the data collection and/or analysis because we chose objective readouts as measure of our experiments. Therefore, the outcome and results were not prone to be influenced by subjective evaluation. Sup. Fig8b was blinded during data collection and analysis. Quantifications of cells in Figure 3g and Sup. Fig. 7a were performed by software independently of human factor.
Reporting for specific materials, systems and methods Flow Cytometry Plots Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation
For human samples: Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll-Hypaque gradient centrifugation. For FACS staining: cells were washed and resuspended in MACS buffer (PBS with 2%FBS and 2 M EDTA), block with 10% human serum in PBS, washed twice and stained in MACS buffer with antibody mix.
For mouse samples: Spleens and peripheral lymph nodes were minced between the 3ml syringe plunger and fine mesh in MACS buffer (PBS with 2%FBS and 2 M EDTA) to obtain single-cell suspensions that were then filtered through a 70 micron filter. After ACK (Ammonium Chloride) lysis of RBCs, cells were washed once and Fc receptors blocked with anti-mouse CD16/32 (2.4G2, Bio X Cell). Cells (1-3 × 106 cells) were incubated with antibodies for 45/60 min on ice.
Mouse and human samples have been stained in round bottom 96 well plate in 20-30ul of antibody mix. Instrument LSRII (BD Biosciences). FACSAria IIIu cell sorter (BD Biosciences).
Software
BD FACSDIVA™ was used to collect flow cytometry data. FlowJo 9.9 software (TreeStar) was used to analyze data.
Cell population abundance Post-sort fractions had more than 95% purify that was verified through flow cytometry analysis on the same FACSAria machine used to sort the cells.
Gating strategy
Initial gating strategy performed: FSC-A/SSC-A, exclusion of doublets (through SSC-H/SSC-W and FSC-H/FSC-W), live cells (negative for Aqua or Near-IR dead stain kit). These were followed by specific gating strategy reported in the figure legends of main and supplementary figures.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
